Latest News

Knocking out cystic fibrosis: CRISPR-Cas may treat the genetic cause

The fight against cystic fibrosis, a genetic disease for which no cure is currently available, continues, targeting in particular some of the mutations that cause it. In a new study, a research team of the Cibio Department of the University of Trento used genome editing to prove the efficacy of CRISPR-Cas to treat the genetic problem that causes the disease.

Source link

Related posts

Study examines whether legal mandates for naloxone coprescription increased naloxone dispensing


Can menopause symptoms lead to chronic pain?


Popular gyms undermining health with tanning beds, researcher says


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy